# SECUADO

NDC: 68968-0174
Generic name: ASENAPINE
Labeler / Manufacturer: Noven Therapeutics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: FILM, EXTENDED RELEASE
Routes: TRANSDERMAL
Marketing started: 20200212

FDA application: NDA212268

## Active ingredients

- ASENAPINE: 7.6 mg/d

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68968-0174"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68968-0174
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=685eaf44-5944-4f38-afba-0a4fc0b3462b